Barak Y - Search Results

1

Longitudinal disability curves for predicting the course of relapsing-remitting multiple sclerosis.

Achiron A, Barak Y, Rotstein Z. Achiron A, et al. Among authors: barak y. Mult Scler. 2003 Oct;9(5):486-91. doi: 10.1191/1352458503ms945oa. Mult Scler. 2003. PMID: 14582775

2

Effect of interferon-beta-1b on cognitive functions in multiple sclerosis.

Barak Y, Achiron A. Barak Y, et al. Eur Neurol. 2002;47(1):11-4. doi: 10.1159/000047940. Eur Neurol. 2002. PMID: 11803186 Clinical Trial.

3

Screening for early cognitive impairment in multiple sclerosis patients using the clock drawing test.

Barak Y, Lavie M, Achiron A. Barak Y, et al. J Clin Neurosci. 2002 Nov;9(6):629-32. doi: 10.1054/jocn.2002.1110. J Clin Neurosci. 2002. PMID: 12604271

4

Bone strength in multiple sclerosis: cortical midtibial speed-of-sound assessment.

Achiron A, Edelstein S, Ziev-Ner Y, Givon U, Rotstein Z, Barak Y. Achiron A, et al. Among authors: barak y. Mult Scler. 2004 Oct;10(5):488-93. doi: 10.1191/1352458504ms1076oa. Mult Scler. 2004. PMID: 15471362

5

Cancer incidence in multiple sclerosis and effects of immunomodulatory treatments.

Achiron A, Barak Y, Gail M, Mandel M, Pee D, Ayyagari R, Rotstein Z. Achiron A, et al. Among authors: barak y. Breast Cancer Res Treat. 2005 Feb;89(3):265-70. doi: 10.1007/s10549-004-2229-4. Breast Cancer Res Treat. 2005. PMID: 15754125 Review.

6

Cognitive fatigue in multiple sclerosis: findings from a two-wave screening project.

Barak Y, Achiron A. Barak Y, et al. J Neurol Sci. 2006 Jun 15;245(1-2):73-6. doi: 10.1016/j.jns.2005.09.015. Epub 2006 Apr 19. J Neurol Sci. 2006. PMID: 16626750

7

Effect of Alfacalcidol on multiple sclerosis-related fatigue: A randomized, double-blind placebo-controlled study.

Achiron A, Givon U, Magalashvili D, Dolev M, Liraz Zaltzman S, Kalron A, Stern Y, Mazor Z, Ladkani D, Barak Y. Achiron A, et al. Among authors: barak y. Mult Scler. 2015 May;21(6):767-75. doi: 10.1177/1352458514554053. Epub 2014 Oct 24. Mult Scler. 2015. PMID: 25344375 Clinical Trial.

8

Perspectives in multiple sclerosis health care: special focus on the costs of multiple sclerosis.

Rotstein Z, Hazan R, Barak Y, Achiron A. Rotstein Z, et al. Among authors: barak y. Autoimmun Rev. 2006 Oct;5(8):511-6. doi: 10.1016/j.autrev.2006.02.001. Epub 2006 Mar 10. Autoimmun Rev. 2006. PMID: 17027884 Review.

9

Intravenous immunoglobulin treatment following the first demyelinating event suggestive of multiple sclerosis: a randomized, double-blind, placebo-controlled trial.

Achiron A, Kishner I, Sarova-Pinhas I, Raz H, Faibel M, Stern Y, Lavie M, Gurevich M, Dolev M, Magalashvili D, Barak Y. Achiron A, et al. Among authors: barak y. Arch Neurol. 2004 Oct;61(10):1515-20. doi: 10.1001/archneur.61.10.1515. Arch Neurol. 2004. PMID: 15477504 Clinical Trial.

10

Dysregulation of affect in multiple sclerosis: new phenomenological approach.

Harel Y, Barak Y, Achiron A. Harel Y, et al. Among authors: barak y. Psychiatry Clin Neurosci. 2007 Feb;61(1):94-8. doi: 10.1111/j.1440-1819.2007.01616.x. Psychiatry Clin Neurosci. 2007. PMID: 17239045 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

534 results

Search Page

Filters